➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: August 5, 2021

DrugPatentWatch Database Preview

Biogen Inc Company Profile

Email this page to a colleague

« Back to Dashboard

US Patents for Biogen Inc

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Biogen Inc. ADUHELM aducanumab INJECTION, SOLUTION 761178 1 2021-06-07 10,703,800 LA JOLLA BIOLOGICS, INC. (San Diego, CA) 2036-04-26 search
Biogen Inc. ADUHELM aducanumab INJECTION, SOLUTION 761178 1 2021-06-07 10,590,182 The Regents of the University of California (Oakland, CA) 2035-02-24 search
Biogen Inc. ADUHELM aducanumab INJECTION, SOLUTION 761178 1 2021-06-07 10,543,283 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, CA) 2033-03-13 search
Biogen Inc. ELOCTATE antihemophilic factor (recombinant), fc fusion protein KIT 125487 1 2014-07-14
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source
Similar Applicant Names
Companies are sometimes listed under multiple names.
This search can help find similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.